In addition, a recent study demonstrated that the bone microenvironment invigorates metastatic seeds for further dissemination by enhancer of zeste homolog 2 (EZH2)-mediated epigenetic reprogramming that confers stem cell-like properties on cancer cells disseminated from bone lesions, thus further negatively impacting patient survival [27]. This evidence concerns the gene EZH2 and cancer.